Developer docs
API playgroundTry for free, no card

Search company profiles

Kadance

Full company profile

uuid006az9o

Namestring
Kadance
Legal namestring
Kadance, Inc.
Websiteurl
kadance.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Kadance (formerly healthōme, Inc.) is a US-based precision health management company founded in 2019 and headquartered at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. Its core offering combines hereditary cancer risk testing (a 26+ gene panel covering BRCA1/2, Lynch syndrome, PALB2 and other clinically actionable genes), pharmacogenomic testing (drug response profiling), genetic counseling, oncology nurse navigation, molecular pathologist consultations, blood-based cancer recurrence monitoring (ctDNA/liquid biopsy), and clinical trial enrollment support into a single membership-based platform. Testing is performed through CAP-accredited, CLIA-certified laboratory partners, including its wholly-owned subsidiary Kailos Genetics and partner lab Protean Biodiagnostics, with care delivery supported by SteadyMD (provider/counselor layer) and GalenusRx (clinical pharmacist consultations).

The commercial model is hybrid. The primary channel is B2B2C enterprise partnerships with life and workplace insurance carriers — notably Chubb Workplace Benefits (Cancer Advocate Plus, launched 2023) and Nationwide (Precision Health Management Program, 2025) — which embed Kadance's services as a policyholder benefit at no incremental cost to the member. A parallel direct-to-consumer channel operates through the Kadance website and member portal (myhealth.kadance.com), offering subscription-based membership tiers named Complete, Navigate, and Recover that target prevention, active cancer patients, and post-treatment survivors, respectively. Pricing is described as subscription/recurring, with insurance coverage or membership fees absorbing service costs and future add-ons contemplated by the Terms of Service.

Kadance monetizes through recurring membership fees and carrier enterprise agreements. Strategic capital partners include American Family Ventures and AllegisNL Capital (seed, 2023) and Nassau Financial Group via the Nassau Reimagine program (2026). The company reports 11–50 employees and is privately held as a Delaware corporation, having been rebranded from healthōme to Kadance in 2023/2024 to align its identity with insurance-channel distribution. Leadership includes Darren Rowe (CEO), David Stertzer (Co-Founder), Terri Kinloch (CXO), Louis Davis (CTO), Kimberly Scott (Chief Commercial Officer), and Chairperson Anne Melissa Dowling, the latter appointed specifically to deepen carrier-side credibility.

Short descriptiontext

Kadance is a US-based precision health management company offering hereditary cancer risk testing, pharmacogenomics, genetic counseling, and oncology nurse navigation, delivered via insurance-carrier partnerships (Chubb, Nationwide) and direct-to-consumer membership.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHuntsville, United States
HQ citystring
Huntsville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision health management, hereditary cancer testing, pharmacogenomic testing, genetic counseling services, oncology nurse navigation
Industry5 codes
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAANAD
Molecular Tumor Boards & Clinical Interpretation Services
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Precision Health Management
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Precision Health Membership Programs
TypeSubscription Recurring
Description

Kadance offers membership-based programs (Complete, Navigate, Recover) that provide access to hereditary cancer risk testing, genetic counseling, and precision health support. Costs for services are covered by membership, insurance policy, or rider to insurance policy, with no additional charges to members for covered services.

kadance.com
2B2B2C Enterprise Partnerships with Insurance Carriers
TypeSubscription Recurring
Description

Kadance partners with insurance carriers (e.g., Nationwide, Chubb) who embed Kadance's precision health program as a benefit for their policyholders. Kadance receives compensation through these enterprise agreements, and policyholders access services at no additional cost through their insurance benefit.

kadance.com
3Future Add-on Services
TypeSubscription Recurring
Description

The Terms of Service indicate that Kadance may offer add-on or additional products and services for which it may charge fees in the future, payable via credit card with applicable taxes and shipping charges.

kadance.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Kadance Complete Membership
ModelSubscriptionBilling cadenceMonthly
Notes

Membership-based pricing covering 26 gene hereditary cancer risk testing, genetic counseling for positive results, prevention planning, and access to coordinated cancer support if cancer is ever diagnosed. No separate fees for testing or counseling. No physician referral required. Costs may be covered by insurance policy or rider.

kadance.com
2Kadance Navigate Membership
ModelSubscriptionBilling cadenceMonthly
Notes

Membership designed for individuals recently diagnosed with cancer or currently in treatment, providing more targeted support for active cancer patients.

kadance.com
3Kadance Recover Membership
ModelSubscriptionBilling cadenceMonthly
Notes

Membership for cancer survivors focused on recurrence monitoring and long-term survivorship care support.

kadance.com
4Insurance-Covered Services
ModelSubscriptionBilling cadenceAnnual
Notes

All costs for Site and Services are covered by membership, insurance policy, or that certain Rider to insurance policy. Neither Kadance nor the Laboratories or Practices or Providers will charge members for Services covered by membership or Insurance Policy and rendered through the Site.

kadance.com
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Core offering1 text field

Kadance operates a genomics-based precision health management platform that delivers hereditary cancer risk testing across 26+ clinically actionable genes, pharmacogenomic (PGx) testing, genetic counseling, oncology nurse navigation, molecular pathologist consultations, and blood-based ctDNA cancer recurrence monitoring. Services are sold as recurring memberships (Complete, Navigate, Recover tiers) directly to consumers and bundled as policyholder benefits through partnerships with major U.S. insurance carriers such as Nationwide and Chubb.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Stage 1 localized cancer detection is associated with approximately 91.1% five-year survival rate vs. approximately 30.6% when cancer has spread
+6 more records
Product and service6 records
1Kadance Complete Membership
CategoryPrecision Health Membership
Description

Subscription membership for prevention-focused individuals delivering hereditary cancer risk testing across 26+ genes, genetic counseling for positive results, prevention planning, and access to coordinated cancer support if cancer is ever diagnosed. No physician referral required; costs covered by membership or insurance policy/rider.

2Kadance Navigate Membership
CategoryPrecision Health Membership
Description

Subscription membership for individuals recently diagnosed with cancer or currently in treatment, providing more targeted precision health support for active cancer patients.

3Kadance Recover Membership
CategoryPrecision Health Membership
Description

Subscription membership for cancer survivors focused on blood-based ctDNA cancer recurrence monitoring and long-term survivorship care support.

4Kadance Precision Health Management Program (Nationwide)
CategoryInsurance-embedded Precision Health Program
Description

Genomics-based health management program embedded as a benefit for eligible Nationwide life insurance policyholders, providing access to DNA testing, pharmacogenomic testing, hereditary cancer risk assessment, and oncology navigation services to support members' health beyond traditional insurance coverage.

5Cancer Advocate Plus (Chubb Workplace Benefits)
CategoryInsurance-embedded Precision Health Program
Description

Genetics-based cancer support program offering cancer screening/risk testing, cancer management support including molecular diagnostic tumor testing and oncology nurse advocacy, cancer recovery monitoring, and insurance benefits, distributed as a voluntary benefit to employees of middle-market and large companies through Chubb Workplace Benefits.

6Genomics-based Personalized Medication Safety Program
CategoryPharmacogenomic Service
Description

Personalized medication safety program combining pharmacogenomic testing with personalized medication guidance and clinical pharmacist consultations through partner GalenusRx to reduce adverse drug events.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-05-15
Description

Nationwide partnered with Kadance to offer a genomics-based health management program for eligible life insurance customers. The program provides access to advanced DNA testing, pharmacogenomic testing, hereditary cancer risk assessment, and oncology navigation services, supporting members' health beyond traditional insurance coverage.

2Chubb Workplace Benefits
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2023-02-21
Description

Chubb Workplace Benefits launched Cancer Advocate Plus, a first-of-its-kind genetics-based cancer support program through an exclusive agreement with Kadance (then healthŌme). The program provides policyholders with genetics-based cancer risk testing, pharmacogenomic testing, cancer management support including molecular diagnostic tumor testing and oncology nurse advocacy, cancer recovery monitoring, and insurance benefits — distributed to employees of middle-market and large companies as a voluntary benefit.

kadance.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

healthŌme (now Kadance) and GalenusRx forged a strategic partnership to launch a genomics-based personalized medication safety program combining pharmacogenomic testing with personalized medication guidance. GalenusRx is one of the Practices referenced in Kadance's Terms of Service that provides clinical pharmacist consultations.

Strategic tierCoreTypeTechnology or Integration
Description

Kailos Genetics, LLC is a wholly owned subsidiary of Kadance, Inc. It serves as one of Kadance's clinical laboratory partners providing genetic testing services. The acquisition of Kailos Genetics strengthened Kadance's integrated precision health management capabilities. Kailos Genetics is a CAP-accredited, CLIA-certified laboratory.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

SteadyMD is one of the licensed medical practices that provides professional genetic testing ordering, interpretation, genetic counseling, and telemedicine services to Kadance members. Kadance facilitates access to SteadyMD's licensed healthcare providers and genetic counselors through its platform.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Protean Biodiagnostics is one of the clinical laboratories and licensed medical practices providing genetic testing, molecular pathologist consultations, and healthcare provider services to Kadance members. It is a CAP-accredited, CLIA-certified laboratory referenced in Kadance's Terms of Service and blog content.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Genomic Life offers genetic testing and precision health programs integrated into insurance products, including employer-sponsored plans. Highly comparable to Kadance's insurtech-genomics business model of embedding testing within carrier benefits.

TypeBroad incumbent
Description

Quest Diagnostics is one of the largest clinical laboratory networks offering hereditary cancer and pharmacogenomic testing. As a broad incumbent, Quest has the scale and payor relationships Kadance lacks, though its offering is not consumer-direct or insurance-embedded.

TypeDirect peer
Description

Natera is a clinical-grade genetic testing company offering hereditary cancer panels, pharmacogenomics, and liquid biopsy recurrence monitoring. Overlaps with Kadance on hereditary cancer testing and ctDNA recurrence monitoring, though Natera operates more on a clinical/provider channel model.

TypeEmerging player
Description

GalenusRx is a pharmacogenomics clinical services firm that is also a strategic partner of Kadance (provides pharmacist consultations). Comparable on PGx clinical service delivery and medication safety programs targeted at insurance/payer customers.

TypeBroad incumbent
Description

23andMe is the largest consumer-facing genetic testing brand, offering hereditary cancer risk reports and pharmacogenomic insights. Competes with Kadance on consumer awareness and direct-to-consumer accessibility, though its tests are not clinical-grade or insurance-embedded.

TypeEmerging player
Description

Invitae (now part of Labcorp) offers comprehensive genetic testing including hereditary cancer panels with a focus on accessibility. Comparable on panel breadth and clinical-grade lab operations; however, it has been navigating financial distress which may affect competitive positioning.

TypeDirect peer
Description

Color is a population genomics company offering hereditary cancer and pharmacogenomic testing to individuals, employers, and health plans. Directly comparable to Kadance in panel scope, clinical-grade lab operations, and B2B2C distribution model targeting large employer and health plan customers.

TypeBroad incumbent
Description

Labcorp is a major clinical laboratory operator offering hereditary cancer panels and now Invitae-powered genetic testing. As a broad incumbent, Labcorp has payor relationships and clinical lab scale that Kadance lacks; competitive threat exists if Labcorp pursues insurance-embedded offerings similar to Kadance's model.

TypeBroad incumbent
Description

Myriad is an established molecular diagnostics company with deep hereditary cancer testing heritage (BRACAnalysis, myRisk). Comparable on hereditary cancer panel offerings and clinical lab operations, though Myriad serves primarily provider channels rather than insurance-embedded benefits.

TypeEmerging player
Description

GenXys is a pharmacogenomics-focused company offering medication safety software and PGx testing. Co-featured alongside Kadance in an Inside Precision Medicine article on pharmacogenomics startups; comparable on the PGx/medication-safety use case embedded into insurance products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Kadance

Precision Health Managementkadance.com

Kadance is a US-based precision health management company offering hereditary cancer risk testing, pharmacogenomics, genetic counseling, and oncology nurse navigation, delivered via insurance-carrier partnerships (Chubb, Nationwide) and direct-to-consumer membership.

What Kadance does

Kadance (formerly healthōme, Inc.) is a US-based precision health management company founded in 2019 and headquartered at the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama. Its core offering combines hereditary cancer risk testing (a 26+ gene panel covering BRCA1/2, Lynch syndrome, PALB2 and other clinically actionable genes), pharmacogenomic testing (drug response profiling), genetic counseling, oncology nurse navigation, molecular pathologist consultations, blood-based cancer recurrence monitoring (ctDNA/liquid biopsy), and clinical trial enrollment support into a single membership-based platform. Testing is performed through CAP-accredited, CLIA-certified laboratory partners, including its wholly-owned subsidiary Kailos Genetics and partner lab Protean Biodiagnostics, with care delivery supported by SteadyMD (provider/counselor layer) and GalenusRx (clinical pharmacist consultations).

The commercial model is hybrid. The primary channel is B2B2C enterprise partnerships with life and workplace insurance carriers — notably Chubb Workplace Benefits (Cancer Advocate Plus, launched 2023) and Nationwide (Precision Health Management Program, 2025) — which embed Kadance's services as a policyholder benefit at no incremental cost to the member. A parallel direct-to-consumer channel operates through the Kadance website and member portal (myhealth.kadance.com), offering subscription-based membership tiers named Complete, Navigate, and Recover that target prevention, active cancer patients, and post-treatment survivors, respectively. Pricing is described as subscription/recurring, with insurance coverage or membership fees absorbing service costs and future add-ons contemplated by the Terms of Service.

Kadance monetizes through recurring membership fees and carrier enterprise agreements. Strategic capital partners include American Family Ventures and AllegisNL Capital (seed, 2023) and Nassau Financial Group via the Nassau Reimagine program (2026). The company reports 11–50 employees and is privately held as a Delaware corporation, having been rebranded from healthōme to Kadance in 2023/2024 to align its identity with insurance-channel distribution. Leadership includes Darren Rowe (CEO), David Stertzer (Co-Founder), Terri Kinloch (CXO), Louis Davis (CTO), Kimberly Scott (Chief Commercial Officer), and Chairperson Anne Melissa Dowling, the latter appointed specifically to deepen carrier-side credibility.

Kadance firmographics

Firmographics
Name
Kadance
Legal name
Kadance, Inc.
Website
https://kadance.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Kadance is a US-based precision health management company offering hereditary cancer risk testing, pharmacogenomics, genetic counseling, and oncology nurse navigation, delivered via insurance-carrier partnerships (Chubb, Nationwide) and direct-to-consumer membership.
Ownership category
akta.pro rank

Kadance industry classification

Industry
Product category
Precision Health Management
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAAANAD
Molecular Tumor Boards & Clinical Interpretation Services
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)

Keywords

  • Precision health management
  • Hereditary cancer testing
  • Pharmacogenomic testing
  • Genetic counseling services
  • Oncology nurse navigation

Where Kadance is headquartered

Location

Headquarters

HQ city
Huntsville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Kadance business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Precision Health Membership Programs: Kadance offers membership-based programs (Complete, Navigate, Recover) that provide access to hereditary cancer risk testing, genetic counseling, and precision health support. Costs for services are covered by membership, insurance policy, or rider to insurance policy, with no additional charges to members for covered services.
  2. B2B2C Enterprise Partnerships with Insurance Carriers: Kadance partners with insurance carriers (e.g., Nationwide, Chubb) who embed Kadance's precision health program as a benefit for their policyholders. Kadance receives compensation through these enterprise agreements, and policyholders access services at no additional cost through their insurance benefit.
  3. Future Add-on Services: The Terms of Service indicate that Kadance may offer add-on or additional products and services for which it may charge fees in the future, payable via credit card with applicable taxes and shipping charges.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyKadance Complete Membership
SubscriptionMonthlyKadance Navigate Membership
SubscriptionMonthlyKadance Recover Membership
SubscriptionAnnualInsurance-Covered Services

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Kadance product offering

Product offering

Core offering

Kadance operates a genomics-based precision health management platform that delivers hereditary cancer risk testing across 26+ clinically actionable genes, pharmacogenomic (PGx) testing, genetic counseling, oncology nurse navigation, molecular pathologist consultations, and blood-based ctDNA cancer recurrence monitoring. Services are sold as recurring memberships (Complete, Navigate, Recover tiers) directly to consumers and bundled as policyholder benefits through partnerships with major U.S. insurance carriers such as Nationwide and Chubb.

Differentiator

Problem solved

Functional benefit

Products and services

  • Kadance Complete Membership Subscription membership for prevention-focused individuals delivering hereditary cancer risk testing across 26+ genes, genetic counseling for positive results, prevention planning, and access to coordinated cancer support if cancer is ever diagnosed. No physician referral required; costs covered by membership or insurance policy/rider.
  • Kadance Navigate Membership Subscription membership for individuals recently diagnosed with cancer or currently in treatment, providing more targeted precision health support for active cancer patients.
  • Kadance Recover Membership Subscription membership for cancer survivors focused on blood-based ctDNA cancer recurrence monitoring and long-term survivorship care support.
  • Kadance Precision Health Management Program (Nationwide) Genomics-based health management program embedded as a benefit for eligible Nationwide life insurance policyholders, providing access to DNA testing, pharmacogenomic testing, hereditary cancer risk assessment, and oncology navigation services to support members' health beyond traditional insurance coverage.
  • Cancer Advocate Plus (Chubb Workplace Benefits) Genetics-based cancer support program offering cancer screening/risk testing, cancer management support including molecular diagnostic tumor testing and oncology nurse advocacy, cancer recovery monitoring, and insurance benefits, distributed as a voluntary benefit to employees of middle-market and large companies through Chubb Workplace Benefits.
  • Genomics-based Personalized Medication Safety Program Personalized medication safety program combining pharmacogenomic testing with personalized medication guidance and clinical pharmacist consultations through partner GalenusRx to reduce adverse drug events.

Quantifiable outcome

  • Stage 1 localized cancer detection is associated with approximately 91.1% five-year survival rate vs. approximately 30.6% when cancer has spread
  • +6 more outcomes

Companies that use Kadance

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Kadance technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Kadance partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • NationwidecoreGTM or Marketing Partner · 15 May 2025Nationwide partnered with Kadance to offer a genomics-based health management program for eligible life insurance customers. The program provides access to advanced DNA testing, pharmacogenomic testing, hereditary cancer risk assessment, and oncology navigation services, supporting members' health beyond traditional insurance coverage.
  • Chubb Workplace BenefitscoreGTM or Marketing Partner · 21 February 2023Chubb Workplace Benefits launched Cancer Advocate Plus, a first-of-its-kind genetics-based cancer support program through an exclusive agreement with Kadance (then healthŌme). The program provides policyholders with genetics-based cancer risk testing, pharmacogenomic testing, cancer management support including molecular diagnostic tumor testing and oncology nurse advocacy, cancer recovery monitoring, and insurance benefits — distributed to employees of middle-market and large companies as a voluntary benefit.
  • healthŌme and GalenusRxcoreStrategic or Co-development PartnerhealthŌme (now Kadance) and GalenusRx forged a strategic partnership to launch a genomics-based personalized medication safety program combining pharmacogenomic testing with personalized medication guidance. GalenusRx is one of the Practices referenced in Kadance's Terms of Service that provides clinical pharmacist consultations.
  • Kailos Genetics, LLCcoreTechnology or IntegrationKailos Genetics, LLC is a wholly owned subsidiary of Kadance, Inc. It serves as one of Kadance's clinical laboratory partners providing genetic testing services. The acquisition of Kailos Genetics strengthened Kadance's integrated precision health management capabilities. Kailos Genetics is a CAP-accredited, CLIA-certified laboratory.
  • SteadyMDcoreImplementation/ SI/ Consulting PartnerSteadyMD is one of the licensed medical practices that provides professional genetic testing ordering, interpretation, genetic counseling, and telemedicine services to Kadance members. Kadance facilitates access to SteadyMD's licensed healthcare providers and genetic counselors through its platform.
  • Protean BiodiagnosticscoreImplementation/ SI/ Consulting PartnerProtean Biodiagnostics is one of the clinical laboratories and licensed medical practices providing genetic testing, molecular pathologist consultations, and healthcare provider services to Kadance members. It is a CAP-accredited, CLIA-certified laboratory referenced in Kadance's Terms of Service and blog content.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Kadance competitors and assessment

Company assessment

Direct peers

  • Genomic Life: Genomic Life offers genetic testing and precision health programs integrated into insurance products, including employer-sponsored plans. Highly comparable to Kadance's insurtech-genomics business model of embedding testing within carrier benefits.
  • Natera: Natera is a clinical-grade genetic testing company offering hereditary cancer panels, pharmacogenomics, and liquid biopsy recurrence monitoring. Overlaps with Kadance on hereditary cancer testing and ctDNA recurrence monitoring, though Natera operates more on a clinical/provider channel model.
  • Color Genomics: Color is a population genomics company offering hereditary cancer and pharmacogenomic testing to individuals, employers, and health plans. Directly comparable to Kadance in panel scope, clinical-grade lab operations, and B2B2C distribution model targeting large employer and health plan customers.

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is one of the largest clinical laboratory networks offering hereditary cancer and pharmacogenomic testing. As a broad incumbent, Quest has the scale and payor relationships Kadance lacks, though its offering is not consumer-direct or insurance-embedded.
  • 23andMe: 23andMe is the largest consumer-facing genetic testing brand, offering hereditary cancer risk reports and pharmacogenomic insights. Competes with Kadance on consumer awareness and direct-to-consumer accessibility, though its tests are not clinical-grade or insurance-embedded.
  • Labcorp: Labcorp is a major clinical laboratory operator offering hereditary cancer panels and now Invitae-powered genetic testing. As a broad incumbent, Labcorp has payor relationships and clinical lab scale that Kadance lacks; competitive threat exists if Labcorp pursues insurance-embedded offerings similar to Kadance's model.
  • Myriad Genetics: Myriad is an established molecular diagnostics company with deep hereditary cancer testing heritage (BRACAnalysis, myRisk). Comparable on hereditary cancer panel offerings and clinical lab operations, though Myriad serves primarily provider channels rather than insurance-embedded benefits.

Emerging players

  • GalenusRx: GalenusRx is a pharmacogenomics clinical services firm that is also a strategic partner of Kadance (provides pharmacist consultations). Comparable on PGx clinical service delivery and medication safety programs targeted at insurance/payer customers.
  • Invitae: Invitae (now part of Labcorp) offers comprehensive genetic testing including hereditary cancer panels with a focus on accessibility. Comparable on panel breadth and clinical-grade lab operations; however, it has been navigating financial distress which may affect competitive positioning.
  • GenXys: GenXys is a pharmacogenomics-focused company offering medication safety software and PGx testing. Co-featured alongside Kadance in an Inside Precision Medicine article on pharmacogenomics startups; comparable on the PGx/medication-safety use case embedded into insurance products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Kadance social profiles

Digital presence

Kadance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Kadance leadership team

Management profile

Number of profiles

Profiles6 records

Kadance subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Kadance funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Kadance M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kadance

What does Kadance do?

Kadance operates a genomics-based precision health management platform that delivers hereditary cancer risk testing across 26+ clinically actionable genes, pharmacogenomic (PGx) testing, genetic counseling, oncology nurse navigation, molecular pathologist consultations, and blood-based ctDNA cancer recurrence monitoring. Services are sold as recurring memberships (Complete, Navigate, Recover tiers) directly to consumers and bundled as policyholder benefits through partnerships with major U.S. insurance carriers such as Nationwide and Chubb.

Is Kadance a public or private company?

Kadance is a private company. It is classified as venture growth investor backed and is currently operating.

When was Kadance founded?

Kadance was founded in 2019. It employs 11 to 50 people.

Where is Kadance based?

Kadance is headquartered in Huntsville, United States, in the North America region.

How does Kadance make money?

Three revenue lines are on record. Precision Health Membership Programs are the primary driver. The others are B2B2C Enterprise Partnerships with Insurance Carriers and future Add-on Services.

Who are Kadance's main competitors?

Direct peers on record are Genomic Life, Natera and Color Genomics. Broad incumbents are Quest Diagnostics, 23andMe, Labcorp and Myriad Genetics. Emerging players are GalenusRx, Invitae and GenXys.

Does Kadance have an API?

No public API is recorded for Kadance.

What industry is Kadance in?

Kadance's product category is Precision Health Management. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 541714 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InsideprecisionmedicineFive Startups Surfing the PGx WaveThis article profiles five pharmacogenomics startups—GenXys, Kadance, NeuroKaire, PGxAI, and Stalicla—as investor interest in the sector grows amid projected market expansion from $7.6 billion in 2024 to $12.4 billion by 2030, with AI tools in the space expected to surge at 23.9% annually to $12.6 billion by 2033. The featured startups have collectively raised over $85 million in recent funding rounds and include acquisitions such as Kadance's purchase of Kailos Genetics and partnerships like NeuroKaire's collaboration with NeuroSense Therapeutics for Alzheimer's drug development. Stalicla notably advanced its autism spectrum disorder candidate STP1 to Phase II, while the broader M&A landscape saw Telos PGx acquired by Principle Health Systems and Corriel Life Sciences by InformedDNA.NationwideNationwide to introduce Kadance Precision Health Management ProgramNationwide announced a partnership with Kadance to offer its Precision Health Management Program, which provides genomics-based insights and personalized care, to eligible life insurance customers. The program is currently available for purchase by policyholders acquired through LIBRA Insurance Partners brokerage agencies. This collaboration aims to provide proactive health support and genetic testing services that extend beyond traditional insurance coverage.PR NewswirehealthŌme, Inc. Announces Rename and Rebrand as Kadance, Inc.healthŌme, Inc. announced its renaming and rebranding to Kadance, Inc. on January 9, 2025, marking a strategic transformation that aligns the company more closely with its mission of integrating genomic insights with precision health solutions. The new Kadance brand, combining the concepts of cadence and dance, reflects a revitalized focus on offering accessible health management through proactive hereditary cancer risk testing, pharmacogenomic testing, and precision cancer management services. The rebranding is effective immediately, with the company and its subsidiary Kailos Genetics, LLC continuing operations from the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama.MorningstarhealthŌme, Inc. Announces Rename and Rebrand as Kadance, Inc.healthŌme, Inc. announced its rename and rebrand to Kadance, Inc., effective immediately. The company, a genomics-based precision health management firm, will offer services like hereditary cancer risk testing and pharmacogenomic testing. The rebrand emphasizes proactive, precise, and personal health guidance.